Metabolic & Cardiometabolic
sourdough bread treats type 2 diabetes / Crohn's disease / ulcerative colitis
In plain terms: Can sourdough bread treat diabetes or inflammatory bowel disease?
Contested Metabolic & Cardiometabolic 🔬 Includes disconfirming
RefutedContestedStrong support
consensus score 0.13
No — there are no controlled trials showing sourdough treats or improves T2D or IBD as diseases; only acute glycemic-response data exist for a separate, weaker claim.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
MechanismIn-vitroAnimalObservationalRCTMeta-analysis
How the studies fall
4 support 1 contradict 0 tested null 6 mixed · 11 sources, 5 independent groups
What the evidence shows
Contested on paper, but in truth untested: no controlled trial has given sourdough bread to people with type 2 diabetes, Crohn's disease or ulcerative colitis and measured the disease.
The evidence (22)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Limketkai BN, Iheozor-Ejiofor Z, Gjuladin-Hellon T, Parian A, Matarese LE, Bracewell K, MacDonald JK, Gordon M, Mullin GE 2019 · Cochrane Database Syst Rev | meta-analysis | contradicts | moderate | OFF-SCOPE: Cochrane review of 18 RCTs (1878 participants) of exclusion diets in IBD; the only bread-containing arm pooled sourdough bread with red meat, butter and oil (Bartel 2008, active Crohn's): 'At 24 weeks, 50% (4/8) of participants in the highly restricted organic diet achieved clinical remission compared to 50% (5/10) of participants in the control group (RR 1.00, 95% CI 0.39 to 2.53; 18 participants; 1 study; very low certainty evidence).' No separate sourdough estimate and no type 2 diabetes outcome; the headline ('The effects of dietary interventions on CD and UC are uncertain') concerns other diets. |
| Nyman M, Nguyen TD, Wikman O, Hjortswang H, Hallert C 2020 · Crohns Colitis 360 | RCT | tested-null | low | OFF-SCOPE: RCT in quiescent ulcerative colitis, 'randomized to eat oat bran or low-fiber wheat products' (60 g/day oat bran vs low-fibre wheat, 24 weeks); no sourdough bread in either arm. 'The oat bran group had significantly ( P < 0.05) higher fecal butyrate concentrations and lower serum LDL levels, while deterioration of gastrointestinal symptoms was prevented'; 'The relapse rate was the same for both diets.' |
| Hjorth T, Schadow A, Revheim I, Spielau U, Meyer K, Rieder A, Varela P, Ballance S, Koerner A, Landberg R, Buyken AE, Dierkes J, Rosendahl-Riise H 2025 · Am J Clin Nutr | RCT | contradicts | moderate | OFF-SCOPE: 16-wk double-blind RCT, n=194 adults at risk of T2D; 'Participants consumed ≥3 slices/d of either β-glucan–enriched bread (6 g β-glucan/d) or control bread' (whole-grain wheat). 'After 16 wk, there was no significant between-group difference in HbA1c [Δ = −0.01%, 95% confidence interval (CI): −0.03, 0.06; P = 0.49].' Sourdough, leavening and fermentation are not mentioned anywhere in the paper; no diagnosed T2D or IBD. |
| Rolim ME, Fortes MI, Von Frankenberg A, Duarte CK 2024 · Crit Rev Food Sci Nutr | meta-analysis | mixed | moderate | Systematic review/meta-analysis of 18 clinical trials found sourdough bread modestly lowers 60-min postprandial glucose vs industrial bread/glucose but shows no effect on treating diabetes as a disease. |
| Barone Lumaga R, Tagliamonte S, De Rosa T, Valentino V, Ercolini D, Vitaglione P 2024 · J Nutr | RCT | supports | moderate | Randomized controlled trial in healthy subjects found a fiber-enriched sourdough-leavened croissant lowered fasting blood glucose. |
| Aune D, Norat T, Romundstad P, Vatten LJ 2013 · Eur J Epidemiol | observational | mixed | moderate | Dose-response meta-analysis of 16 cohorts linked whole-grain intake to ~21% lower type 2 diabetes incidence, a prevention association, not treatment of established disease. |
| Lioger D, Fardet A, Foassert P, Davicco MJ, Mardon J, Gaillard-Martinie B, Remesy C 2009 · J Sci Food Agric | RCT | supports | low | Small crossover in healthy subjects found sourdough prefermentation lowered postprandial glucose and insulin responses versus non-fermented product. |
| Ghanbari-Gohari F, Mousavi SM, Esmaillzadeh A 2022 · Food Sci Nutr | observational | mixed | low | Meta-analysis of 11 cohorts (463,282 people) found highest vs lowest whole-grain intake associated with 21% lower type-2-diabetes risk (contextual, not sourdough-specific). |
| Chatonidi G, Rosseel R, Dalile B, Satriawan D, Vandermeulen G, Van Holm B, Comer L, Maes P, Everaert N, Courtin CM, Verbeke K 2026 · Appetite | RCT | mixed | moderate | Double-blind crossover RCT (n=44 healthy adults) found whole-meal sourdough leavening did not meaningfully improve postprandial glucose, insulin, or appetite versus yeast bread. |
| Ribet L, Dessalles R, Lesens C, Brusselaers N, Durand-Dubief M 2023 · Adv Nutr | RCT | mixed | moderate | Systematic review of 25 RCTs (542 subjects) concluded no clear consensus that sourdough per se benefits glucose/GI health, with effects dependent on strain and fermentation conditions. |
| Liljeberg H, Bjorck I 1996 · Eur J Clin Nutr | mechanism | supports | low | Human/rat mechanistic study attributed lowered post-meal glycemia after sourdough to organic-acid-slowed gastric emptying, a postprandial mechanism only, not disease treatment. |
| Laatikainen R, Koskenpato J, Hongisto SM, Loponen J, Poussa T, Huang X, Sontag-Strohm T, Salmenkari H, Korpela R 2017 · Nutrients | RCT | contradicts | low | Randomised, double-blind, parallel-group 7-day trial in 26 adults with Rome III irritable bowel syndrome and self-reported wheat intolerance (13 per arm); organic GI disease 'such as inflammatory bowel disease or celiac disease' was an exclusion criterion. Sourdough vs yeast-fermented wheat bread differed by 4 mm (95% CI -4 to 11, p = 0.33) on the gastrointestinal VAS total; IL-6, IL-8 and LBP did not differ. No glycaemic, diabetes or inflammatory-bowel-disease outcome was measured. |
| Muir JG, Varney JE, Ajamian M, Gibson PR 2019 · Int J Food Microbiol | mechanism | supports | moderate | OFF-SCOPE: clinical-perspective narrative review (Monash FODMAP group). Its only sourdough statement: 'The use of sourdough cultures in bread making has been shown to reduce the quantities of FODMAPs (mostly fructan), resulting in bread products that are well tolerated by patients with IBS.' IBS (irritable bowel syndrome) is not IBD; no type 2 diabetes, Crohn's or ulcerative colitis data. Also a review - no independent observation. |
| Limketkai BN, Gordon M, Mutlu EA, De Silva PS, Lewis JD 2020 · Inflamm Bowel Dis | meta-analysis | contradicts | moderate | REVIEW: commentary by the Cochrane authors on their own review, no new data: 'The article comments on the recent systematic review and meta-analysis of dietary interventions for Crohn's disease and ulcerative colitis.' It restates the review's estimates (e.g. highly restricted organic diet RR 1.00; 95% CI 0.39-2.53; 1 study with 18 participants) and cautions: 'Notably, this is not the same as demonstrating lack of efficacy in any of the individual studies, rather, that the analyses demonstrate no definite conclusions can be reached based on the available evidence to date.' No sourdough estimate, no type 2 diabetes outcome. Zero weight; duplicates s30736095. |
| Korem T, Zeevi D, Zmora N, Weissbrod O, Bar N, Lotan-Pompan M, Avnit-Sagi T, Kosower N, Malka G, Rein M, Suez J, Goldberg BZ, Weinberger A, Levy AA, Elinav E, Segal E 2017 · Cell Metab | RCT | contradicts | moderate | Randomized crossover of sourdough vs white bread found no significant differential clinical effect; glycemic response was person-specific, not bread-type specific. |
| Menezes LAA, Minervini F, Filannino P, Sardaro MLS, Gatti M, Lindner JD 2018 · Front Microbiol | observational | tested-null | low | Review documenting how sourdough fermentation degrades FODMAPs in bread with potential GI-symptom benefit for IBS patients. |
| Fernández-Bañares F, Hinojosa J, Sánchez-Lombraña JL, Navarro E, Martínez-Salmerón JF, García-Pugés A, González-Huix F, Riera J, González-Lara V, Domínguez-Abascal F, Giné JJ, Moles J, Gomollón F, Gassull MA 1999 · Am J Gastroenterol | RCT | mixed | moderate | OFF-SCOPE: open-label RCT, 'A total of 105 patients with ulcerative colitis who were in remission were randomized into groups to receive oral treatment with Plantago ovata seeds (10 g b.i.d.), mesalamine (500 mg t.i.d.), and Plantago ovata seeds plus mesalamine at the same doses.' 'After 12 months, treatment failure rate was 40% (14 of 35 patients) in the Plantago ovata seed group, 35% (13 of 37) in the mesalamine group, and 30% (nine of 30) in the Plantago ovata plus mesalamine group.' 'Probability of continued remission was similar (Mantel-Cox test, p = 0.67; intent-to-treat analysis).' The exposure is psyllium-seed fibre, not sourdough bread. |
| Ying T, Zheng J, Kan J, Li W, Xue K, Du J, Liu Y, He G 2024 · Nutr J | meta-analysis | mixed | moderate | Dose-response meta-analysis found whole grains aid diabetes prevention in cohorts but RCT glycemic effects were weaker and inconsistent, undercutting a "treats diabetes" claim for grain breads. |
| Polese B, Nicolai E, Genovese D, Verlezza V, La Sala CN, Aiello M, Inglese M, Incoronato M, Sarnelli G, De Rosa T, Schiatti A, Mondelli F, Ercolini D, Cuomo R 2018 · J Nutr | RCT | supports | low | Acute randomized study found sourdough bakery products produced different postprandial GI function (less fullness/bloating) than brewer's-yeast products in healthy adults. |
| Breen C, Ryan M, Gibney MJ, Corrigan M, O'Shea D 2013 · Diabetes Educ | observational | mixed | low | Postprandial study in type 2 diabetes patients found bread type modulated glucose/insulin/appetite responses acutely but tested no disease-treatment endpoint. |
| Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L 2019 · Lancet | meta-analysis | mixed | high | Fibre/whole-grain SR/MA series; 'We excluded prospective studies and trials reporting on participants with a chronic disease' and 'Our findings are limited to risk reduction in the population at large rather than those with chronic disease.' No sourdough and no disease treatment studied; off-scope. ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Loponen, Gänzle 2018 · Foods | observational | mixed | low | Narrative review of sourdough and FODMAPs; it reports no measurements of its own. Its clinical section summarises two randomized double-blind crossover trials in irritable bowel syndrome patients: low-FODMAP rye bread 'caused less flatulence, less abdominal pain, fewer cramps, and less stomach rumbling than regular rye bread' and 'reduced the generation of hydrogen by colonic fermentation', while retaining 'a high dietary fiber content (10 g/100 g)'. The paper does not report participant numbers, and reports no data on type 2 diabetes, Crohn's disease or ulcerative colitis. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.